Anthony Petrello the Highest Paid CEO

Anthony Petrello the Highest Paid CEO

Anthony Petrello is an excellent example of living the American Dream. He was brought up in Newark in a working – class community. With a good education and hard work, he used his talent which was natural to become the highest earning CEO in America. He has a Bachelor and a Master in Mathematics and Ph.D. in law from Harvard Law School.

He was employed by Baker & McKenzie one of the best New York law firms after attaining law Doctorate. His hard work, talent, and discipline made him become the Managing Director of the company’s New York office by 1986. His exemplary work led him to be hired by Nabor Industries as Chief Operating Officer by 1991.

In the same year that he was appointed, he was elected to the board of directors and acceded to the Executive Committee of the Board. He has served the capacity the Executive of Deputy Chairman, President, Chairman of the Board and also as a Chairman of the Executive Committee. He has also held positions as the Director of Texas Hospital and Director of Stewart & Stevenson.

Nabor Industries

Anthony Petrello is in charge of strategic planning and general operations at Nabors Industries. He has achieved massive success in the competitive oils market due to his expertise in this area. Nabor Industries is involved in contract drilling as it is an oilfield service company. It has approximately 500 drilling rigs making it one of the companies largest collections of the drilling rigs in the world in 25 different countries.

When it comes to compensation Nabor Industries has a history of compensating its workers higher. During 2015 financial year proxy statements showed Anthony Petrello received $ 27,512,939 in total compensation. His annual pay comprises of base salary and bonuses that every year the company files with SEC.

Anthony Petrello is married his to Cynthia Petrello who was his college sweetheart; she is an actress and producer. Their daughter who was born prematurely has cerebral palsy. Texas Children Hospital where the diagnosis of her condition was made has benefitted from the generosity of Anthony Petrello. He is one of the biggest contributors and donors for neurological research at the center, and he is a Director at the facility.

JeanMarie Guenot’s Stellar Career

JeanMarie Guenot is a highly successful businesswoman that has worked for a variety of pharmaceutical and business companies. As of 2013, she is currently the CEO and President of Amphivena Therapeutics. Amphivena Therapeutics is a biotech company in San Francisco, California that specializes in treating hematological cancer with immunotherapy.

She attended the University of California and graduated with a Ph.D. in 1993. Following graduation, she worked for six years at Hoffman-Loche as a team leader and principal scientist. Guenot attended the Wharton School of the University of Pennsylvania and graduated with an MBA. Upon graduation, she began working at Atlas Venture as a business consultant. In 2003, Guenot became the Vice President of PDL BioPharma, which is a company that helps treat cancer and immune system diseases. In 2009, JeanMarie Guenot became a managing partner of Guenot, LLC. In the same year, she founded SKS Ocular LLC, a biotech company in San Diego, California. In 2013, she became the President and CEO at her current job, Amphivena Therapeutics. She resides over the development of research that specializes in treating blood cancers.

Read more: Maverick Therapeutics and Takeda Announce Five-year Collaboration to Advance T-Cell Engagement Therapies

JeanMarie Guenot’s involvement at Amphivena Therapeutics is essential in treating severe blood disorders. Currently, the company plans to develop a therapy that uses the patient’s immune system to fight deadly diseases. They hope to one day have a cure for multiple myeloma and leukemia. In August 2016, the FDA approved an investigational new drug to treat acute myeloid leukemia and is now being tested in clinical trials on

As you can see, JeanMarie Guenot is a highly accomplished individual in the pharmaceutical field. She has dedicated her career to the research and development of medical drugs that may one day help find the cure for cancer. Under her guidance, Amphivena Therapeutics will continue to be at the forefront of medical research for many years to come.

Learn more about Jeanmarie Guenot: